Exclusive Distribution Deal Expands ViaCLYR™ Reach to 500M People in MENA
BLGO is trading near its 52-week low of $0.138 (13% above the low).
Summary
BioLargo's subsidiary, Clyra Medical Technologies, has signed an exclusive distribution agreement with Al-Hikma FZCO to commercialize its ViaCLYR™ advanced wound irrigation solution across the Middle East, North Africa, and adjacent markets, a region with over 500 million people. This agreement significantly expands Clyra Medical's international footprint and commercialization potential for a key product. The deal with an established regional distributor like Al-Hikma FZCO, which has already begun country-level regulatory work, represents a material step forward for the small-cap company. This follows a recent Memorandum of Understanding with Aquatech, indicating a strategic focus on leveraging partnerships for market expansion. Investors should monitor the progress of regulatory approvals and initial sales performance in these new territories.
At the time of this announcement, BLGO was trading at $0.16 on OTC in the Life Sciences sector, with a market capitalization of approximately $50.3M. The 52-week trading range was $0.14 to $0.26. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Access Newswire.